Gelsolin induces promonocytic leukemia differentiation accompanied by upregulation of p21CIP1

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4827-4834

  Shirkoohi, Reza ^a,b   Fujita, Hisakazu ^b,c   Darmanin, Stephanie ^d   Takimoto, Masato ^b,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Research Section of Disease Control   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Actin; Differentiation; Gelsolin; Promonocytic leukemia

Indexed keywords

EID: 84874008965     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4827     Document Type: Article

References (42)

1. Banno Y, Fujita H, Ono Y, et al (1999). Differential phospholipase D activation by bradykinin and sphingosine 1-phosphate in NIH 3T3 fibroblasts overexpressing gelsolin. J Biol Chem, 274, 27385-91.
2. Bhat R, Malinge S, Gamis A, et al (2009). Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia. Leukemia, 23, 2159-60.
3. Cervio C, Barsotti D, Ibanez J, et al (2012). Early mortality in children with advanced mature b-cell malignancies in a middle-income country. J Pediatr Hematol Oncol, 34, 266-70.
4. Craig C, Schiller G (2008). Acute myeloid leukemia in the elderly: conventional and novel treatment approaches. Blood Rev, 22, 221-34.
5. Dieffenbach C, SenGupta D, Krause D, Swazak D, Silverman. RH (1989). Cloning of murine gelsolin and its regulation during differentiation of embryonal carcinoma cells. J Biol Chem, 264, 13281-8.
6. Dong Z, Arnold R, Yang Y, et al (2005). Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis. Mol Cell Proteomics, 4, 993-1001.
7. Fredly H, Ersvxr E, Stapnes C, Gjertsen B, Bruserud Q (2009). The combination of conventional chemotherapy with new targeted therapy in hematologic malignancies: The safety and efficiency of low-dose cytarabine supports its combination with new therapeutic agents in early clinical trials. Current Cancer Therapy Rev, 5, 243-55.
8. Fujita H, Okada F, Hamada J, et al (2001). Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int J Cancer, 93, 773-80.
9. Furnish E, Zhou W, Cunningham C, Kas J, Schmidt CE (2001). Gelsolin overexpression enhances neutrite outgrowth in PC12 cells. FEBS Letters, 508, 282-6.
10. Germain P CP, Eichele G, Evans RM, et al (2006). International union of pharmacology. LX. Retinoic acid receptors. Pharmacol Rev, 58, 712-25.
11. Goodrich D (2006). The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene, 25, 5233-43.
12. Humeniuk R, Mishra P, Bertino J, Banerjee D (2009). Molecular targets for epigenetic therapy of cancer. Curr Pharm Biotechnol, 10, 161-5.
13. Jiang F, Guo N, Dusting G (2008). Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3',4'-dihydroxyflavonol in phagocytic and vascular cells. J Pharmacol Exp Ther, 324, 261-9.
14. Kim J, Feldman R (2002). Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol and Cell Biochem, 22, 1903-18.
15. Koeffler H (2010). Is there a role for differentiating therapy in non-APL AML?. Best Pract Res Clin Haematol, 23, 503-8.
16. Koschmieder S, Agrawal S, Radomska H, et al (2007). Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation. Int J Oncol, 30, 349-55.
17. Kuzumaki N, Maruta H (2002). Cytoskeletal tumor suppressor Genes, tumor-suppressing viruses. genes and drugs innovative cancer therapy approach, 177-197.
18. Kwaitkowski D (1988). Predominant induction of gelsolin and actin binding protein during myeloid differentiation. J Biol Chem, 263, 13857-62.
19. Lai D, Visser-Grieve S, Yang X (2012). Tumour suppressor genes in chemotherapeutic drug response. Biosci Rep, 32, 361-74.
20. Li G, Arora P, Chen Y, McCulloch C, Liu P (2012). Multifunctional roles of gelsolin in health and diseases. Med Res Rev, 32, 999-1025.
21. Liang H, Samanta S, Nagarajan L (2005). SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells. Oncogene, 24, 2625-34.
22. Mak K, Funnell A, Pearson R, Crossley M (2011). PU.1 and Haematopoietic Cell Fate: Dosage Matters. Int J Cell Biol, VOL?, PAGE?-?.
23. Matsuzaki K, Minami T, Tojo M, et al (2003). PML-nuclear bodies are involved in cellular serum response. Genes Cells, 8, 275-86.
24. Miranda M, McGuire T, Johnson D (2002). Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia, 16, 683-92.
25. Moosavi M, Yazdanparast R (2008). Distinct MAPK signaling pathways, p21 up-regulation and caspase-mediated p21 cleavage establishes the fate of U937 cells exposed to 3-hydrogenkwadaphnin: differentiation versus apoptosis. Toxicol Appl Pharmacol, 230, 86-96.
26. Nam K, Choi M, Yoo E, Paeng D (2011). Influence of cell packing by centrifugation on 40-MHz ultrasound backscatter. Ultrasonics, 51, 197-201.
27. O'Donnell M, Abboud C, Altman J, et al (2012). Acute myeloid leukemia. J Natl Compr Canc Netw, 10, 984-1021.
28. Ory D, Neugeboren B, Mulligan R (1996). A stable humanderived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA, 93, 11400-6.
29. Patel D, Ahmad S, Weiss D, Gerke V, Kuznetsov S (2011). Annexin A1 is a new functional linker between actin filaments and phagosomes during phagocytosis. J Cell Sci, 124, 578-88.
30. Petrie K, Zelent A, Waxman S (2009). Differentiation therapy of acute myeloid leukemia: past, present and future. Current Opinion in Hematology, 16, 84-91.
31. Sagawa N, Fujita H, Banno Y, et al (2003). Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10. Br J Cancer, 88, 606-12.
32. Sato M, Maruoka M, Takeya T (2012). Functional mechanisms and roles of adaptor proteins in Abl-regulated cytoskeletal actin dynamics. JOURNAL?, VOL?, PAGE ?-?.
33. Sazawa A, Watanabe T, Tanaka M, et al (2002). Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice. J Urol, 168, 1182-7.
34. Shima Y, Kitabayashi I (2011). Deregulated transcription factors in leukemia. Int J Hematol, 94, 134-41.
35. Spike B, Wahl G (2011). p53, stem cells, and reprogramming: tumor suppression beyond guarding the genome. Genes Cancer, 2, 404-19.
36. Tanaka H, Shirkoohi R, Nakagawa K, et al (2006). siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells. Int J Cancer, 118, 1680-91.
37. Ullmannová V, Stöckbauer P, Hradcová M, Soucek J, Haskovec C (2003). Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. Leuk Res, 27, 1115-23.
38. Verdijk P, van Veelen P, de Ru A, et al (2004). Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Eur J Immunol, 34, 156-64.
39. Wiernik P (2011). Acute lymphoblastic leukemia of adulthood: progress or not?. Curr Treat Options Oncol, 12, 303-11.
40. Yamamoto T, N Sakaguchi, Hachiya M, et al (2009). Role of catalase in monocytic differentiation of U937 cells by TPA:hydrogen peroxide as a second messengerRole of catalase in monocytic differentiation. Leukemia, 23, 761-9.
41. Zeng H, Davis C (2003). Down-regulation of proliferating cell nuclear antigen gene expression occurs during cell cycle arrest induced by human fecal water in colonic HT-29 cells. J Nutr, 133, 2682-7.
42. Zhao J, Zhang L, Zhang Y, Shen Y (2012). The differential regulation of Gap43 gene in the neuronal differentiation of P19 cells. J Cell Physiol, 227, 2645-53.